IGC earnings: a negative outcome, -14.5%

On June 24, 2024, IGC Pharma, Inc. reached its earnings. The result was a negative outcome, and the stock moved -14.5% in the window around the event. It had already run +12.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.